J Adv Pract Oncol. 2019 Aug;10(6):601-609. doi: 10.6004/jadpro.2019.10.6.10. Epub 2019 Aug 1.
, of the Memorial Sloan Kettering Cancer Center, and of St. Joseph's/Candler Health System offer an advanced practitioner perspective on trials assessing the efficacy and safety of novel agents in smoldering and relapsed/refractory multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia.
纪念斯隆凯特琳癌症中心的[具体人员未提及]以及圣约瑟夫/坎德勒健康系统的[具体人员未提及]就评估新型药物在冒烟型和复发/难治性多发性骨髓瘤、慢性淋巴细胞白血病和急性髓细胞白血病中的疗效和安全性的试验提供了高级从业者的观点。